Temko and colleagues demonstrated that acquisition of POLE mutations induces a distinct pattern of mutations in cancer driver genes, a substantially increased mutation burden, and an enhanced immune response that is detectable even in precancerous lesions [14]. Here, POLE is linked to cancer.